KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $102,291 | -83.7% | 57,146 | -6.0% | 0.00% | -66.7% |
| Q2 2021 | $627,000 | -93.9% | 60,786 | -93.8% | 0.00% | -94.6% |
| Q1 2021 | $10,314,000 | -32.0% | 980,464 | 0.0% | 0.06% | -52.1% |
| Q4 2020 | $15,178,000 | +594.3% | 980,464 | +554.7% | 0.12% | +350.0% |
| Q3 2020 | $2,186,000 | +1038.5% | 149,752 | +1397.5% | 0.03% | +1200.0% |
| Q1 2020 | $192,000 | -77.3% | 10,000 | -45.1% | 0.00% | -88.9% |
| Q2 2014 | $847,000 | – | 18,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |